FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2132000864> ?p ?o ?g. }

• W2132000864 endingPage "57" @default.
• W2132000864 startingPage "46" @default.
• W2132000864 abstract "Background. Treatment of hepatitis C virus (HCV) infection with newer direct-acting antivirals is unrealistic in some countries because of the lack of availability. Aim. Assess benefits and harms of boceprevir (BOC) and telaprevir (TLV) in treatment of genotype 1 HCV infection, and identifying subgroups with most benefit. Material and methods. Search from 2009-2013 in PubMed, EMBASE, and “gray literature” of published and unpublished randomized trials reporting sustained viral response (SVR) or adverse events (AE) with BOC or TLV + pegylated interferon and ribavirin (PR) in HCV-infected patients; cohorts or case reports for comparison protease inhibitors (PI), evaluation of predictors of SVR, and resistant variants. Cochrane guidelines were applied. Comparisons between PI + PR vs. PR were performed. Main outcomes were expressed as risk-ratios with 95% CIs. Meta-regression and trial sequential analysis were performed. Results. 33 studies (10,525 patients) were analyzed. SVR was higher for PI + PR (RR, 2.05; 95% CI 1.70-2.48). In meta-regression, previously treated patients exhibited greater benefit from PI + PR (RR, 3.47; 95% CI, 2.78-4.33). AE were higher with PI + PR (RR, 1.01; 95% CI, 1-1.03; NNH 77.59), also the discontinuation rate (RR, 1.69; 95% CI, 1.36-2.10, NNH, 18). Predictors of SVR were IL-28 TT, nonblack race, low viral load, age, no cirrhosis, statin use, undetectable viral load at the first anemia episode and at week 2 of treatment, and low IL-6 levels. In conclusion SVR was higher in patients treated with PIs, patients previously exposed to PR showed superior response rates. Specific predictors will determine the best candidates for treatments that will offer real-life therapeutic alternatives." @default.
• W2132000864 created "2016-06-24" @default.
• W2132000864 creator A5033059979 @default.
• W2132000864 creator A5037581187 @default.
• W2132000864 creator A5049290235 @default.
• W2132000864 creator A5069074260 @default.
• W2132000864 creator A5081427073 @default.
• W2132000864 creator A5083350507 @default.
• W2132000864 date "2015-01-01" @default.
• W2132000864 modified "2023-10-18" @default.
• W2132000864 title "Boceprevir and telaprevir for chronic genotype 1 hepatitis C virus infection. A systematic review and meta-analysis" @default.
• W2132000864 cites W1586232317 @default.
• W2132000864 cites W1963818433 @default.
• W2132000864 cites W1965358723 @default.
• W2132000864 cites W1969215054 @default.
• W2132000864 cites W1972226211 @default.
• W2132000864 cites W1974688612 @default.
• W2132000864 cites W1977651219 @default.
• W2132000864 cites W1978892007 @default.
• W2132000864 cites W1979174109 @default.
• W2132000864 cites W1980430543 @default.
• W2132000864 cites W1984160171 @default.
• W2132000864 cites W1987008774 @default.
• W2132000864 cites W1989831705 @default.
• W2132000864 cites W2017412627 @default.
• W2132000864 cites W2038374218 @default.
• W2132000864 cites W2038394941 @default.
• W2132000864 cites W2044786295 @default.
• W2132000864 cites W2046658390 @default.
• W2132000864 cites W2063859957 @default.
• W2132000864 cites W2077714426 @default.
• W2132000864 cites W2080484450 @default.
• W2132000864 cites W2089835531 @default.
• W2132000864 cites W2098923148 @default.
• W2132000864 cites W2100797437 @default.
• W2132000864 cites W2104103604 @default.
• W2132000864 cites W2107512529 @default.
• W2132000864 cites W2110897864 @default.
• W2132000864 cites W2114999139 @default.
• W2132000864 cites W2119764771 @default.
• W2132000864 cites W2125963799 @default.
• W2132000864 cites W2131011125 @default.
• W2132000864 cites W2141214317 @default.
• W2132000864 cites W2143559032 @default.
• W2132000864 cites W2153052034 @default.
• W2132000864 cites W2160984629 @default.
• W2132000864 cites W2172262571 @default.
• W2132000864 cites W2284964401 @default.
• W2132000864 cites W2325179304 @default.
• W2132000864 cites W2327910060 @default.
• W2132000864 doi "https://doi.org/10.1016/s1665-2681(19)30800-2" @default.
• W2132000864 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25536641" @default.
• W2132000864 hasPublicationYear "2015" @default.
• W2132000864 type Work @default.
• W2132000864 sameAs 2132000864 @default.
• W2132000864 citedByCount "17" @default.
• W2132000864 countsByYear W21320008642015 @default.
• W2132000864 countsByYear W21320008642016 @default.
• W2132000864 countsByYear W21320008642017 @default.
• W2132000864 countsByYear W21320008642018 @default.
• W2132000864 countsByYear W21320008642019 @default.
• W2132000864 countsByYear W21320008642020 @default.
• W2132000864 countsByYear W21320008642021 @default.
• W2132000864 crossrefType "journal-article" @default.
• W2132000864 hasAuthorship W2132000864A5033059979 @default.
• W2132000864 hasAuthorship W2132000864A5037581187 @default.
• W2132000864 hasAuthorship W2132000864A5049290235 @default.
• W2132000864 hasAuthorship W2132000864A5069074260 @default.
• W2132000864 hasAuthorship W2132000864A5081427073 @default.
• W2132000864 hasAuthorship W2132000864A5083350507 @default.
• W2132000864 hasBestOaLocation W21320008641 @default.
• W2132000864 hasConcept C126322002 @default.
• W2132000864 hasConcept C142462285 @default.
• W2132000864 hasConcept C159047783 @default.
• W2132000864 hasConcept C168563851 @default.
• W2132000864 hasConcept C197934379 @default.
• W2132000864 hasConcept C2522874641 @default.
• W2132000864 hasConcept C2776408679 @default.
• W2132000864 hasConcept C2776461080 @default.
• W2132000864 hasConcept C2777159539 @default.
• W2132000864 hasConcept C2778159067 @default.
• W2132000864 hasConcept C2778715236 @default.
• W2132000864 hasConcept C2780040827 @default.
• W2132000864 hasConcept C44249647 @default.
• W2132000864 hasConcept C71924100 @default.
• W2132000864 hasConcept C82789193 @default.
• W2132000864 hasConcept C90924648 @default.
• W2132000864 hasConceptScore W2132000864C126322002 @default.
• W2132000864 hasConceptScore W2132000864C142462285 @default.
• W2132000864 hasConceptScore W2132000864C159047783 @default.
• W2132000864 hasConceptScore W2132000864C168563851 @default.
• W2132000864 hasConceptScore W2132000864C197934379 @default.
• W2132000864 hasConceptScore W2132000864C2522874641 @default.
• W2132000864 hasConceptScore W2132000864C2776408679 @default.
• W2132000864 hasConceptScore W2132000864C2776461080 @default.
• W2132000864 hasConceptScore W2132000864C2777159539 @default.
• W2132000864 hasConceptScore W2132000864C2778159067 @default.
• W2132000864 hasConceptScore W2132000864C2778715236 @default.

• next